RiverVest Venture Fund IV, L.P.
Insider CIK 1725443 · RPHM 10% owner · SPRB 10% owner · XLO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 359,324 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 832,120 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy | 2021-10-26 | 2021-10-26 | 250,000 | $16.00 | $4.00M | 1,441,444 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 832,120 | — | $0 | 832,120 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 359,324 | — | $0 | 1,191,444 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion deriv | 2021-04-09 | 2021-04-13 | 4,925,711 | — | $0 | 0 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion deriv | 2021-04-09 | 2021-04-13 | 3,710,116 | — | $0 | 0 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion | 2021-04-09 | 2021-04-13 | 829,113 | — | $0 | 2,209,220 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | P Buy | 2021-04-09 | 2021-04-13 | 200,000 | $15.00 | $3.00M | 2,409,220 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion | 2021-04-09 | 2021-04-13 | 1,100,765 | — | $0 | 1,380,107 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 5,416,666 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 7,000,000 | — | $0 | 0 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | C Conversion | 2020-10-14 | 2020-10-16 | 828,109 | — | $0 | 1,898,281 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | P Buy | 2020-10-14 | 2020-10-16 | 250,000 | $15.00 | $3.75M | 2,148,281 | SEC↗ |
| SPRB SPRUCE BIOSCIENCES, INC. | C Conversion | 2020-10-14 | 2020-10-16 | 1,070,172 | — | $0 | 1,070,172 | SEC↗ |